Publications directory

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 618

Cover image of 'Panobinostat (Farydak®)'

Panobinostat (Farydak®) (January 2019)

Myeloma UK

This Treatment Guide contains information about panobinostat, a drug used in the treatment of myeloma. It describes what it is, how it works, how it is given, and the possible side-effects.

Cover image of 'Reolysin®'

Reolysin® (July 2019)

Myeloma UK

Reolysin, also known as pelareorep, is a type of oncolytic virus being investigated for the treatment of myeloma and various other cancers. This factsheet explains what reolysin is, how it works, and the current evidence to support its use in the treatment of myeloma. It also describes the known possible side-effects, and the availability of reolysin in the UK.

Cover image of 'Dexamethasone'

Dexamethasone (January 2019)

Myeloma UK

Dexamethasone is a steroid drug used in the treatment of myeloma. It belongs to a class of steroids called glucocorticoids. This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Cover image of 'Trastuzumab (Herceptin)'

Trastuzumab (Herceptin) (February 2019)

Breast Cancer Care

This booklet explains what trastuzumab is, how it works, when it may be prescribed and the side effects you may experience. 

Cover image of 'Splenectomy (having your spleen removed)'

Splenectomy (having your spleen removed) (March 2019)

Lymphoma Action

This factsheet has information for people with lymphoma who have had their spleen removed. It describes the function of the spleen, what happens when it is removed and how to reduce the risk of infection.

Cover image of 'Peripheral neuropathy'

Peripheral neuropathy (April 2019)

Lymphoma Action

Peripheral neuropathy may be a side-effect of chemotherapy. This factsheet describes peripheral neuropathy, the chemotherapy drugs that most commonly cause it, the symptoms and diagnosis, reducing the risk and managing the symptoms.

Cover image of 'Idelalisib'

Idelalisib (October 2019)

Lymphoma Action

Idelalisib is a targeted drug used in the treatment of certain types of lymphoma. This factsheet explains what it is, who can have it, how it is given, the benefits and possible side effects.

Cover image of 'Elotuzumab (Empliciti®)'

Elotuzumab (Empliciti®) (November 2019)

Myeloma UK

Elotuzumab is a new drug that is being investigated for the treatment of myeloma. This factsheet describes briefly what it is, how it works, how it is given, the possible benefits over existing drugs, the possible side-effects, its availability in the UK, and the future.

Cover image of 'Fertility, pregnancy and breast cancer'

Fertility, pregnancy and breast cancer (October 2019)

Breast Cancer Now

This booklet is about breast cancer treatment and fertility. It describes how treatment for primary breast cancer may affect a woman’s fertility, and possible ways of preserving fertility. It also includes information about pregnancy after a diagnosis of breast cancer, and permanent infertility. 

Cover image of 'CAR T cells'

CAR T cells (October 2019)

Lymphoma Action

CAR T-cell therapy, is a type of targeted treatment used for certain types of high-grade (fast-growing) lymphoma. This factsheet explains what CAR T cells are, who can have them and how they are given, the benefits, and the possible side effects.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm